Picture of Acotec Scientific Holdings logo

6669 Acotec Scientific Holdings Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for Acotec Scientific Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M
Source:PROSPECTUSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinal
fx
Preliminary
Net Income/Starting Line-31.4-67.270.314.5
Depreciation
Amortisation
Non-Cash Items56.767-5.46-5.47
Unusual Items
Other Non-Cash Items
Changes in Working Capital-39.4-19.9-153-68.1
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-8.77-10.5-68.8-12.9
Capital Expenditures-18.6-21.2-46.7-79.7
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.8920.762-2.47-240
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-17.7-20.5-49.2-319
Financing Cash Flow Items-4.03-67.2-1.76-9.96
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1431,024-32.9-23.2
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash116990-151-349